Last reviewed · How we verify

Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan

NCT02648217 PHASE3 COMPLETED Results posted

This trial is conducted in Africa and Asia. The aim of this trial is to compare efficacy and safety of insulin degludec/insulin aspart twice daily and biphasic insulin aspart twice daily in subjects with type 2 diabetes mellitus before, during and after Ramadan.

Details

Lead sponsorNovo Nordisk A/S
PhasePHASE3
StatusCOMPLETED
Enrolment263
Start dateMon Jan 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionMon Sep 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

South Africa, Malaysia, United Arab Emirates, Lebanon, Algeria, India